Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Sale of 11,939 AUPH shares, $190.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale | 11,939 | $190.4K |
| Aug 26, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale | 20,975 | $355.9K |
| May 20, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 115,541 | n/a |
| Mar 3, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 59,090 | n/a |
| Feb 23, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax Withholding | 34,638 | $498.8K |
| Jan 5, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 48,558 | n/a |
| Mar 5, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 84,106 | n/a |
| Mar 7, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale | 57,745 | $323.4K |
| Feb 22, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 194,230 | n/a |
| Mar 6, 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 204,810 | n/a |